You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 283 No. 11, March 15, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Scoring the Quality of Clinical Trials

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Jüni and colleagues1 compared 25 checklists from systematic reviews. We agree that readers should be critical of the heterogeneity of the content and results of checklists. Therefore, empirical studies in this field are useful. However, by using the same collection of checklists as Moher et al,2 Jüni et al portray an unfair representation of the scientific development of research groups. Our list,3 which Jüni et al included in their analysis, was developed in 1990 and published in 1991. Thereafter, however, we have changed and hopefully improved our checklist, according to the new insights provided by Moher et al4 and others. This has resulted in an updated version of our checklist, which has been published in the method guidelines for systematic reviews within the Cochrane Back Review Group.5 The updated checklist has already been used in several protocols and reviews in the module of the Back Review . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Peter Jüni, Anne Witschi, Ralph Bloch, and Matthias Egger
JAMA. 1999;282(11):1054-1060.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.